Insulin Secretion of Mixed Insulinoma Aggregates-gelatin Hydrogel Microspheres After Subcutaneous Transplantation

Overview

Journal Regen Ther

Date 2018 Oct 2

PMID 30271864

Citations 1

Authors

Kanako Inoo

Hiroto Bando

Yasuhiko Tabata

Affiliations

Soon will be listed here.

Abstract

Introduction: The objective of this study is to evaluate the insulin secretion of mixed aggregates of insulinoma cells (INS-1) and gelatin hydrogel microspheres after their subcutaneous transplantation.

Methods: Gelatin hydrogel microspheres were prepared by the conventional w/o emulsion method. Cell aggregates mixed with or without the hydrogel microspheres were encapsulated into a pouched-device of polytetrafluoroethylene membrane. An agarose hydrogel or MedGel™ incorporating basic fibroblast growth factor (bFGF) was subcutaneously implanted to induce vascularization. After the vascularization induction, cell aggregates encapsulated in the pouched-device was transplanted.

Results: The vascularization had the potential to enable transplanted cell aggregates to enhance the level of insulin secretion compared with those of no vascularization induction. In addition, the insulin secretion of cell aggregates was significantly promoted by the mixing of gelatin hydrogel microspheres even in the pouched-device encapsulated state.

Conclusion: It is possible that the microspheres mixing gives cells in aggregates better survival condition, resulting in promoted insulin secretion.

Citing Articles

A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-β1 release system.

Nii T, Makino K, Tabata Y Regen Ther. 2020; 14:196-204.

PMID: 32154334 PMC: 7058408. DOI: 10.1016/j.reth.2020.02.003.

References

Tabata Y, Ikada Y . Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 1999; 20(22):2169-75. DOI: 10.1016/s0142-9612(99)00121-0. View

Ryan E, Lakey J, Rajotte R, Korbutt G, Kin T, Imes S . Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001; 50(4):710-9. DOI: 10.2337/diabetes.50.4.710. View

Luan N, Iwata H . Long-term allogeneic islet graft survival in prevascularized subcutaneous sites without immunosuppressive treatment. Am J Transplant. 2014; 14(7):1533-42. DOI: 10.1111/ajt.12739. View

Hayashi K, Tabata Y . Preparation of stem cell aggregates with gelatin microspheres to enhance biological functions. Acta Biomater. 2011; 7(7):2797-803. DOI: 10.1016/j.actbio.2011.04.013. View

Sakuma Y, Ricordi C, Miki A, Yamamoto T, Pileggi A, Khan A . Factors that affect human islet isolation. Transplant Proc. 2008; 40(2):343-5. PMC: 2614209. DOI: 10.1016/j.transproceed.2007.12.019. View

Tajima S, Tabata Y . Preparation and functional evaluation of cell aggregates incorporating gelatin microspheres with different degradabilities. J Tissue Eng Regen Med. 2012; 7(10):801-11. DOI: 10.1002/term.1469. View

Tung Y, Hsiao A, Allen S, Torisawa Y, Ho M, Takayama S . High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst. 2010; 136(3):473-8. PMC: 7454010. DOI: 10.1039/c0an00609b. View

Kinoshita N, Echigo Y, Shinohara S, Gu Y, Miyazaki J, Inoue K . Regulation of cell proliferation using tissue engineering in MIN6 cells. Cell Transplant. 2001; 10(4-5):473-7. View

Sart S, Ma T, Li Y . Preconditioning stem cells for in vivo delivery. Biores Open Access. 2014; 3(4):137-49. PMC: 4120806. DOI: 10.1089/biores.2014.0012. View

10.

Moriarty N, Pandit A, Dowd E . Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation. Sci Rep. 2017; 7(1):16033. PMC: 5700093. DOI: 10.1038/s41598-017-15970-w. View

11.

Lanza R, Hayes J, Chick W . Encapsulated cell technology. Nat Biotechnol. 1996; 14(9):1107-11. DOI: 10.1038/nbt0996-1107. View

12.

Huang Y, Marui A, Sakaguchi H, Esaki J, Arai Y, Hirose K . Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia. Circ J. 2008; 72(10):1693-9. DOI: 10.1253/circj.cj-07-0960. View

13.

Veriter S, Gianello P, Igarashi Y, Beaurin G, Ghyselinck A, Aouassar N . Improvement of subcutaneous bioartificial pancreas vascularization and function by coencapsulation of pig islets and mesenchymal stem cells in primates. Cell Transplant. 2013; 23(11):1349-64. DOI: 10.3727/096368913X663550. View

14.

Terrovitis J, Ruckdeschel Smith R, Marban E . Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res. 2010; 106(3):479-94. PMC: 2826722. DOI: 10.1161/CIRCRESAHA.109.208991. View

15.

Nyitray C, Chang R, Faleo G, Lance K, Bernards D, Tang Q . Polycaprolactone Thin-Film Micro- and Nanoporous Cell-Encapsulation Devices. ACS Nano. 2015; 9(6):5675-82. PMC: 4628825. DOI: 10.1021/acsnano.5b00679. View

16.

Feener E, King G . Vascular dysfunction in diabetes mellitus. Lancet. 1997; 350 Suppl 1:SI9-13. DOI: 10.1016/s0140-6736(97)90022-2. View

17.

van der Windt D, Echeverri G, IJzermans J, Cooper D . The choice of anatomical site for islet transplantation. Cell Transplant. 2009; 17(9):1005-14. View

18.

Xia Y, Zhu K, Lai H, Lang M, Xiao Y, Lian S . Enhanced infarct myocardium repair mediated by thermosensitive copolymer hydrogel-based stem cell transplantation. Exp Biol Med (Maywood). 2014; 240(5):593-600. PMC: 4935272. DOI: 10.1177/1535370214560957. View

19.

Kriz J, Vilk G, Mazzuca D, Toleikis P, Foster P, White D . A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg. 2011; 203(6):793-7. DOI: 10.1016/j.amjsurg.2011.02.009. View

20.

Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S . Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A. 2003; 65(4):489-97. DOI: 10.1002/jbm.a.10542. View